TABLE 2.
Summarized effects of TCM Corydalis and Stephania therapy on METH abuse and other psychiatric symptoms.
| Herb | Compound | Types of functional impairment | Symptoms and experiment | Animal | Effective dose | Receptor or signaling pathway molecule | Author [Ref.] |
|---|---|---|---|---|---|---|---|
| Corydalis and Stephania | l-THP | METH dependence | METH self-administration and METH-induced reinstatement | Rat | l-THP 5 mg/kg | DA receptor | Gong et al. (2016) |
| CPP | Mice | l-THP (10 and 20 mg/kg) | Su et al. (2013) | ||||
| l-THP 10 mg/kg | ERK phosphorylation | Su et al. (2020) | |||||
| Behavioral sensitization | Locomotor activity | Rat and mice | l-THP (10 and 15 mg/kg) | 5-HT and D3 receptor | Yun (2014a) | ||
| Memory and cognitive function impairment | Spatial memory impairment | Mice | l-THP (10 and 20 mg/kg) | DA receptor | Cao et al. (2018) | ||
| l-SPD | Behavioral sensitization | Locomotor sensitization behavior | Rat | l-SPD (5 and 10 mg/kg, i.p.) | DA receptor | Ma et al. (2014) | |
| Memory and cognitive function impairment | Memory deficits | Mice | l-SPD (10 mg/kg, i.p.) | Dopaminergic pathway and HCN1 channels | Zhou et al. (2019) | ||
| l-SLR | Behavioral sensitization | Behavioral sensitization | Mice | l-SLR (5 mg/kg) | D2 receptor antagonist, D1 receptor agonist | Mi et al. (2016) | |
| METH dependence | CPP | ||||||
| Anxiety-like behaviors | Anxiety-like behaviors | Zebrafish | 5-HT1A receptor partial agonist |
METH = methamphetamine; 5-HT = 5-hydroxytryptamine; D or DA = dopamine; ERK = extracellular-regulated kinase; HCN1 = hyperpolarization-activated and cyclic nucleotide-gated cation 1; l-THP = l-tetrahydropalmatine; l-SPD = l-stepholidine; l-SLR = l-scoulerine; CPP = conditioned place preference.